Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer’s disease: relevance for precision medicine in neurodegenerative diseases
Simone Lista, Andrea Vergallo, Stefan Teipel, Pablo Lemercier, Filippo Sean Giorgi, Audrey Gabelle, Francesco Garaci, Nicola Biagio Mercuri, Claudio Babiloni, Bhakta Prasad Gaire, Yosef Koronyo, Maya Koronyo‐Hamaoui, Harald Hampel, Robert Nisticò
Topics & Concepts
AcetylcholinesteraseDiseaseMedicineAlzheimer's diseaseRelevance (law)Precision medicineDegenerative diseaseNeurosciencePharmacologyInternal medicinePsychologyPathologyBiologyEnzymeBiochemistryLawPolitical scienceCholinesterase and Neurodegenerative DiseasesAlzheimer's disease research and treatmentsNeurological Disorders and Treatments